骨・関節用健康サプリメントの世界市場 (種類別・流通チャネル別・形状別・対象消費者別・地域別)：動向分析、競合市場シェア、将来予測 (2018年～2028年)

世界の骨・関節用健康サプリメントの市場規模は、2021年に103億1,000万米ドルに達した後、9.2%のCAGRで成長し、2028年末には約188億3,000万米ドルに達すると予測されています。市場成長の主な要因として、栄養補助食品に対する高齢化社会の欲求の高まりや、アクティブな生活に対する消費者の関心の高まり、可処分所得の増加、健康意識の高まりなどが挙げられます。一方、高い研究開発投資と臨床試験のコストが市場成長の妨げとなっています。

当レポートでは、世界の骨・関節用健康サプリメント市場について分析し、市場の基本構造や促進・抑制要因、市場全体および種類別・用途別・地域別の動向見通し、市場戦略の傾向と事例、主要企業のプロファイルなどについて調査しております。

目次

第1章 分析のフレームワーク

第2章 エグゼクティブサマリー

第3章 世界の骨・関節用健康サプリメント市場：産業分析

• 業界のバリューチェーン分析
• DROC分析
  • 促進要因
    • 栄養強化製品の小売売上高の増加
    • ビタミンD欠乏症の一般化による需要の拡大見通し
    • 健康意識の高まりによる、顧客の嗜好の変化
    • 人口の高齢化による市場拡大の促進
  • 抑制要因
    • 多額の研究開発投資と臨床試験の高コスト
  • 機会
    • 骨粗鬆症患者数の増加見通しと需要の拡大
    • 微量栄養素欠乏症に関する消費者の意識を満たすための食品強化
  • 課題
    • 栄養補助食品に関連する消費者の懐疑論
    • 規制の影響
• 技術進歩/近年の動向
• 規制枠組み
• ポーターのファイブフォース分析

第4章 世界の骨・関節用健康サプリメント市場：概要

• 市場規模とその予測 (2018年～2028年)
  • 金額ベース (単位：10億米ドル)
• 市場シェアとその予測
  • 種類別
    • ビタミンD
    • ビタミンK
    • カルシウム
    • コラーゲン
    • オメガ3脂肪酸
    • グルコサミン・コンドロイチン
    • その他
  • 流通チャネル別
    • スーパーマーケット/ハイパーマーケット
    • 薬局・ドラッグストア
    • 健康・美容品店
    • その他
  • 形状別
    • 錠剤
    • カプセル
    • 液体
    • 粉末
    • その他
  • 対象消費者別
    • 幼児
    • 児童
    • 成人
    • 妊婦
    • 高齢者
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第5章 北米の骨・関節用健康サプリメント市場

• 市場規模とその予測 (金額ベース、2018年～2028年)
• 市場シェアとその予測
  • 種類別
  • 流通チャネル別
  • 形状別
  • 対象消費者別
  • 国別
    • 米国
    • カナダ

第6章 欧州の骨・関節用健康サプリメント市場

• 市場規模とその予測 (金額ベース、2018年～2028年)
• 市場シェアとその予測
  • 国別
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • オランダ
    • ベルギー
    • 北欧諸国
    • 他の欧州諸国

第7章 アジア太平洋の骨・関節用健康サプリメント市場

• 市場規模とその予測 (金額ベース、2018年～2028年)
• 市場シェアとその予測
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア・ニュージーランド
    • インドネシア
    • マレーシア
    • シンガポール
    • フィリピン
    • ベトナム
    • 他のアジア太平洋諸国

第8章 ラテンアメリカの骨・関節用健康サプリメント市場

• 市場規模とその予測 (金額ベース、2018年～2028年)
• 市場シェアとその予測
  • 国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • ペルー
    • コロンビア
    • 他のラテンアメリカ諸国

第9章 中東・アフリカの骨・関節用健康サプリメント市場

• 市場規模とその予測 (金額ベース、2018年～2028年)
• 市場シェアとその予測
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • クウェート
    • イラン
    • 南アフリカ
    • ナイジェリア
    • ケニア
    • エジプト
    • モロッコ
    • アルジェリア
    • 他の中東・アフリカ諸国

第10章 競合情勢

• 主要企業とその製品の一覧
• 骨・関節用健康サプリメント企業の市場シェア分析 (2021年)
• 競合ベンチマーク：パラメーター別
• 主要戦略の展開状況 (企業合併・買収 (M&A)、事業提携)

第11章 世界の骨・関節用健康サプリメント市場に対するCOVID-19の影響

第12章 企業プロファイル（企業概要、財務マトリックス、競合情勢、企業役員、主な競合企業、連絡先情報、戦略的展望、SWOT分析)

• Bayer AG
• Procter & Gamble
• Amway
• BASF SE
• Archer Daniels Midland
• Reckitt Benckiser
• Pfizer
• Vita Life Sciences Ltd
• Arazo Nutrition
• Nature's Sunshine Products, Inc
• Glanbia Plc
• Vitawin
• Nutramax Laboratories Consumer Care, Inc
• Simply Supplements
• Love Life Supplements
• Now Foods
• Bellavita Healthcare Pvt Ltd
• Vitaco
• Nutravita
• Life Extension
• Pure Encapsulations, LLC
• Herbs Nutriproducts Pvt. Ltd.
• Millennium Herbal Care
• その他の企業

第13章 主な戦略提言

第14章 分析手法

Global Bone & Joint Health Supplements Market to Grow at a CAGR of 9.2%, during Forecast Period

Global Bone & Joint Health Supplements Market is thriving owing to the rising awareness of micronutrient inadequacies, rising access to supplements, availability of multiple products, and rising numbers of distribution channels.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Bone & Joint Health Supplements Market was worth USD 10.31 billion in the year 2021. The market is projected to grow at a CAGR of 9.2%, earning revenues of around USD 18.83 billion by the end of 2028. The key driver for the growth of the Global Bone & Joint Health Supplements Market is the aging population's increased desire for dietary supplements. Throughout the anticipated period, it is estimated that the market for supplements for bone and joint health would have significant revenue growth due to the aging baby boomer population and the rise in lifestyle disorders. Moreover, increasing consumer interest in active living, rising disposable income, and expanding health consciousness are further significant drivers of the sector. However, high R&D investments and the high cost of clinical trials hinder market growth.

Growing Consumer Awareness of Micronutrient Deficiencies

Rising consumer knowledge of nutritional deficiencies' prevalence and dangers. Additionally, as more people become aware of how nutritional deficiencies can be remedied by supplementation, the demand for products that support bone and joint health will rise, further boosting the market growth. More people are selecting healthier supplements because nutrition and health are directly intertwined. Middle-class incomes are increasing in several regions of Asia, Latin America, and Africa, enabling consumers to spend more on dietary, nutritional, and food supplements. This results in offering lucrative opportunities for the Global Bone & Joint Health Supplements Market during the forecast period (2022-2028).

Aging Population Supports Market Growth

The elderly population is focusing on adjusting to supplements that are specifically tailored to their needs to maintain their good health and quality of life. As people age, they go through several changes, including psychological, physiological, and social ones that affect how they eat. The older population increasingly relies on individualized dietary regimens and routine meal selections. To maintain their general health, the aging populations of many countries have increased the demand for age-friendly dietary options with improved nutritional value.

Challenge: Regulatory Influence

Numerous changes in the industry are being brought about by the general shift in consumer trends. Regulations and requirements relating to nutrition obtained from dietary supplements are evolving. These laws were created in response to evolving nutritional care standards. The FDA and FSSAI have introduced some of these rules. These rules apply to probiotic and prebiotic foods as well as dietary supplements and foods for special diets. The Food and Nutrition Board of the National Academy of Medicine has established recommended dietary allowances and safe upper limits. The quality, efficacy, and safety of supplements for bone and joint health face regulatory obstacles. Regulations governing supplements including vitamins and omega fatty acids sold in South Africa ensure that each product is registered with and approved by SAHPRA. The market as a whole may face serious obstacles as a result of these new restrictions.

Segmental Coverage

Global Bone & Joint Health Supplements Market - By Form

Based on the form, the Global Bone & Joint Health Supplements Market is segmented into Tablets, Capsules, Liquid, Powder, and Others. During the forecast period, the tablet segment is anticipated to develop at the greatest CAGR. Due to the simple availability of varied dosage patterns, simple packaging, storage, and cost-effectiveness, the tablet form of bone and joint health supplements is frequently used. Tablet-based supplements for bone and joint health are ingested because they contain a variety of nutrients, including vitamins and omega-3 fatty acids. Due to their long shelf lives compared to other forms of nutritional supplements, tablets are also favored. The benefits of compressed tablets are their general stability and wide range of sizes and shapes. As a result, it is simple to mix a variety of nutritious supplements into tablet form. Because of this, compresses tablets are popular.

Impact of COVID-19 on Global Bone & Joint Health Supplements Market

To avoid COVID-19, international health agencies such as the World Health Organization (WHO) advise consumers to boost their immune systems. Nutraceuticals with immune-boosting qualities, such as collagen, vitamins, and calcium, are predicted to gain popularity. As a result of the COVID-19 epidemic, the population is embracing social distance and following the trend of working from home or remaining at home, causing consumers to modify their regular habits, such as becoming more health concerned, resulting in an unprecedented level of supplement demand. Consumers' need for self-care is fueling the growth of bone and joint supplements. Customers went out more to hunt for these things during the closure, so the category grew. People are getting more concerned about their health as the population grows.

Competitive Landscape

The leading market players in the Global Bone & Joint Health Supplements Market are Bayer AG, Procter & Gamble, Amway, BASF SE, Archer Daniels Midland, Reckitt Benckiser, Pfizer, Vita Life Sciences Ltd, Arazo Nutrition, Nature's Sunshine Products, Inc, Glanbia Plc, Vitawin, Nutramax Laboratories Consumer Care, Inc, Simply Supplements, Love Life Supplements, Now Foods, Bellavita Healthcare Pvt Ltd, Vitaco, Nutravita, Life Extension, Pure Encapsulations, LLC, Herbs Nutriproducts Pvt. Ltd., Millennium Herbal Care, and other prominent players. The Global Bone & Joint Health Supplements Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Bone & Joint Health Supplements Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Bone & Joint Health Supplements Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Type Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Bone & Joint Health Supplements Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Rising retail sale of nutritional & fortified products
    • 3.2.1.2. Demand is anticipated to increase as vitamin D deficiency becomes more common worldwide
    • 3.2.1.3. Changing customer preferences as a result of increased health awareness
    • 3.2.1.4. Aging population to fuel market expansion
  • 3.2.2. Restraints
    • 3.2.2.1. High R&D investments and high cost of clinical trials
  • 3.2.3. Opportunity
    • 3.2.3.1. The number of people who have osteoporosis is expected to increase, driving demand
    • 3.2.3.2. Food fortification to satisfy consumer awareness about micronutrient deficiencies
  • 3.2.4. Challenges
    • 3.2.4.1. Consumer skepticism associated with nutraceutical products
    • 3.2.4.2. Regulatory influence
• 3.3. Technology Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Bone & Joint Health Supplements Market Overview

• 4.1. Market Size & Forecast, by Value, 2018-2028
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share & Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Vitamin D
    • 4.2.1.2. Vitamin K
    • 4.2.1.3. Calcium
    • 4.2.1.4. Collagen
    • 4.2.1.5. Omega-3 Fatty acids
    • 4.2.1.6. Glucosamine-Chondroitin
    • 4.2.1.7. Others
  • 4.2.2. By Distribution channels
    • 4.2.2.1. Supermarkets/hypermarkets
    • 4.2.2.2. Pharmacies & drug stores
    • 4.2.2.3. Health & beauty stores
    • 4.2.2.4. Others
  • 4.2.3. By Form
    • 4.2.3.1. Tablets
    • 4.2.3.2. Capsules
    • 4.2.3.3. Liquid
    • 4.2.3.4. Powder
    • 4.2.3.5. Others
  • 4.2.4. By Target consumers
    • 4.2.4.1. Infants
    • 4.2.4.2. Children
    • 4.2.4.3. Adults
    • 4.2.4.4. Pregnant woman
    • 4.2.4.5. Elderly people
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia Pacific (APAC)
    • 4.2.5.4. Latin America
    • 4.2.5.5. Middle East and Africa (MEA)

5. North America Bone & Joint Health Supplements Market

• 5.1.1. Market Size & Forecast, by Value, 2018-2028
• 5.1.2. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Distribution channels
  • 5.2.3. By Form
  • 5.2.4. By Target consumers
  • 5.2.5. By Country
    • 5.2.5.1. United States
    • 5.2.5.1.1. By Type
    • 5.2.5.1.2. By Distribution channels
    • 5.2.5.1.3. By Form
    • 5.2.5.1.4. By Target consumers
    • 5.2.5.2. Canada
    • 5.2.5.2.1. By Type
    • 5.2.5.2.2. By Distribution channels
    • 5.2.5.2.3. By Form
    • 5.2.5.2.4. By Target consumers

6. Europe Bone & Joint Health Supplements Market

• 6.1. Market Size & Forecast, by Value, 2018-2028
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Distribution channels
  • 6.2.3. By Form
  • 6.2.4. By Target consumers
  • 6.2.5. By Country
    • 6.2.5.1. Germany
    • 6.2.5.1.1. By Type
    • 6.2.5.1.2. By Distribution channels
    • 6.2.5.1.3. By Form
    • 6.2.5.1.4. By Target consumers
    • 6.2.5.2. United Kingdom
    • 6.2.5.2.1. By Type
    • 6.2.5.2.2. By Distribution channels
    • 6.2.5.2.3. By Form
    • 6.2.5.2.4. By Target consumers
    • 6.2.5.3. Italy
    • 6.2.5.3.1. By Type
    • 6.2.5.3.2. By Distribution channels
    • 6.2.5.3.3. By Form
    • 6.2.5.3.4. By Target consumers
    • 6.2.5.4. France
    • 6.2.5.4.1. By Type
    • 6.2.5.4.2. By Distribution channels
    • 6.2.5.4.3. By Form
    • 6.2.5.4.4. By Target consumers
    • 6.2.5.5. Spain
    • 6.2.5.5.1. By Type
    • 6.2.5.5.2. By Distribution channels
    • 6.2.5.5.3. By Form
    • 6.2.5.5.4. By Target consumers
    • 6.2.5.6. The Netherlands
    • 6.2.5.6.1. By Type
    • 6.2.5.6.2. By Distribution channels
    • 6.2.5.6.3. By Form
    • 6.2.5.6.4. By Target consumers
    • 6.2.5.7. Belgium
    • 6.2.5.7.1. By Type
    • 6.2.5.7.2. By Distribution channels
    • 6.2.5.7.3. By Form
    • 6.2.5.7.4. By Target consumers
    • 6.2.5.8. NORDIC Countries
    • 6.2.5.8.1. By Type
    • 6.2.5.8.2. By Distribution channels
    • 6.2.5.8.3. By Form
    • 6.2.5.8.4. By Target consumers
    • 6.2.5.9. Rest of Europe
    • 6.2.5.9.1. By Type
    • 6.2.5.9.2. By Distribution channels
    • 6.2.5.9.3. By Form
    • 6.2.5.9.4. By Target consumers

7. Asia Pacific Bone & Joint Health Supplements Market

• 7.1. Market Size & Forecast, by Value, 2018-2028
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Distribution channels
  • 7.2.3. By Form
  • 7.2.4. By Target consumers
  • 7.2.5. By Country
    • 7.2.5.1. China
    • 7.2.5.1.1. By Type
    • 7.2.5.1.2. By Distribution channels
    • 7.2.5.1.3. By Form
    • 7.2.5.1.4. By Target consumers
    • 7.2.5.2. India
    • 7.2.5.2.1. By Type
    • 7.2.5.2.2. By Distribution channels
    • 7.2.5.2.3. By Form
    • 7.2.5.2.4. By Target consumers
    • 7.2.5.3. Japan
    • 7.2.5.3.1. By Type
    • 7.2.5.3.2. By Distribution channels
    • 7.2.5.3.3. By Form
    • 7.2.5.3.4. By Target consumers
    • 7.2.5.4. South Korea
    • 7.2.5.4.1. By Type
    • 7.2.5.4.2. By Distribution channels
    • 7.2.5.4.3. By Form
    • 7.2.5.4.4. By Target consumers
    • 7.2.5.5. Australia & New Zealand
    • 7.2.5.5.1. By Type
    • 7.2.5.5.2. By Distribution channels
    • 7.2.5.5.3. By Form
    • 7.2.5.5.4. By Target consumers
    • 7.2.5.6. Indonesia
    • 7.2.5.6.1. By Type
    • 7.2.5.6.2. By Distribution channels
    • 7.2.5.6.3. By Form
    • 7.2.5.6.4. By Target consumers
    • 7.2.5.7. Malaysia
    • 7.2.5.7.1. By Type
    • 7.2.5.7.2. By Distribution channels
    • 7.2.5.7.3. By Form
    • 7.2.5.7.4. By Target consumers
    • 7.2.5.8. Singapore
    • 7.2.5.8.1. By Type
    • 7.2.5.8.2. By Distribution channels
    • 7.2.5.8.3. By Form
    • 7.2.5.8.4. By Target consumers
    • 7.2.5.9. Philippines
    • 7.2.5.9.1. By Type
    • 7.2.5.9.2. By Distribution channels
    • 7.2.5.9.3. By Form
    • 7.2.5.9.4. By Target consumers
    • 7.2.5.10. Vietnam
    • 7.2.5.10.1. By Type
    • 7.2.5.10.2. By Distribution channels
    • 7.2.5.10.3. By Form
    • 7.2.5.10.4. By Target consumers
    • 7.2.5.11. Rest of Asia Pacific
    • 7.2.5.11.1. By Type
    • 7.2.5.11.2. By Distribution channels
    • 7.2.5.11.3. By Form
    • 7.2.5.11.4. By Target consumers

8. Latin America Bone & Joint Health Supplements Market

• 8.1. Market Size & Forecast, by Value, 2018-2028
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Distribution channels
  • 8.2.3. By Form
  • 8.2.4. By Target consumers
    • 8.2.4.1. Brazil
    • 8.2.4.1.1. By Type
    • 8.2.4.1.2. By Distribution channels
    • 8.2.4.1.3. By Form
    • 8.2.4.1.4. By Target consumers
    • 8.2.4.2. Mexico
    • 8.2.4.2.1. By Type
    • 8.2.4.2.2. By Distribution channels
    • 8.2.4.2.3. By Form
    • 8.2.4.2.4. By Target consumers
    • 8.2.4.3. Argentina
    • 8.2.4.3.1. By Type
    • 8.2.4.3.2. By Distribution channels
    • 8.2.4.3.3. By Form
    • 8.2.4.3.4. By Target consumers
    • 8.2.4.4. Peru
    • 8.2.4.4.1. By Type
    • 8.2.4.4.2. By Distribution channels
    • 8.2.4.4.3. By Form
    • 8.2.4.4.4. By Target consumers
    • 8.2.4.5. Colombia
    • 8.2.4.5.1. By Type
    • 8.2.4.5.2. By Distribution channels
    • 8.2.4.5.3. By Form
    • 8.2.4.5.4. By Target consumers
    • 8.2.4.6. Rest of Latin America
    • 8.2.4.6.1. By Type
    • 8.2.4.6.2. By Distribution channels
    • 8.2.4.6.3. By Form
    • 8.2.4.6.4. By Target consumers

9. Middle East & Africa Bone & Joint Health Supplements Market

• 9.1. Market Size & Forecast, by Value, 2018-2028
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Distribution channels
  • 9.2.3. By Form
  • 9.2.4. By Target consumers
  • 9.2.5. By Country
    • 9.2.5.1. Saudi Arabia
    • 9.2.5.1.1. By Type
    • 9.2.5.1.2. By Distribution channels
    • 9.2.5.1.3. By Form
    • 9.2.5.1.4. By Target consumers
    • 9.2.5.2. UAE
    • 9.2.5.2.1. By Type
    • 9.2.5.2.2. By Distribution channels
    • 9.2.5.2.3. By Form
    • 9.2.5.2.4. By Target consumers
    • 9.2.5.3. Qatar
    • 9.2.5.3.1. By Type
    • 9.2.5.3.2. By Distribution channels
    • 9.2.5.3.3. By Form
    • 9.2.5.3.4. By Target consumers
    • 9.2.5.4. Kuwait
    • 9.2.5.4.1. By Type
    • 9.2.5.4.2. By Distribution channels
    • 9.2.5.4.3. By Form
    • 9.2.5.4.4. By Target consumers
    • 9.2.5.5. Iran
    • 9.2.5.5.1. By Type
    • 9.2.5.5.2. By Distribution channels
    • 9.2.5.5.3. By Form
    • 9.2.5.5.4. By Target consumers
    • 9.2.5.6. South Africa
    • 9.2.5.6.1. By Type
    • 9.2.5.6.2. By Distribution channels
    • 9.2.5.6.3. By Form
    • 9.2.5.6.4. By Target consumers
    • 9.2.5.7. Nigeria
    • 9.2.5.7.1. By Type
    • 9.2.5.7.2. By Distribution channels
    • 9.2.5.7.3. By Form
    • 9.2.5.7.4. By Target consumers
    • 9.2.5.8. Kenya
    • 9.2.5.8.1. By Type
    • 9.2.5.8.2. By Distribution channels
    • 9.2.5.8.3. By Form
    • 9.2.5.8.4. By Target consumers
    • 9.2.5.9. Egypt
    • 9.2.5.9.1. By Type
    • 9.2.5.9.2. By Distribution channels
    • 9.2.5.9.3. By Form
    • 9.2.5.9.4. By Target consumers
    • 9.2.5.10. Morocco
    • 9.2.5.10.1. By Type
    • 9.2.5.10.2. By Distribution channels
    • 9.2.5.10.3. By Form
    • 9.2.5.10.4. By Target consumers
    • 9.2.5.11. Algeria
    • 9.2.5.11.1. By Type
    • 9.2.5.11.2. By Distribution channels
    • 9.2.5.11.3. By Form
    • 9.2.5.11.4. By Target consumers
    • 9.2.5.12. Rest of Middle East & Africa
    • 9.2.5.12.1. By Type
    • 9.2.5.12.2. By Distribution channels
    • 9.2.5.12.3. By Form
    • 9.2.5.12.4. By Target consumers

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Bone & Joint Health Supplements Company Market Share Analysis, 2021
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

11. Impact of Covid-19 on Global Bone & Joint Health Supplements Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT)

• 12.1. Bayer AG
• 12.2. Procter & Gamble
• 12.3. Amway
• 12.4. BASF SE
• 12.5. Archer Daniels Midland
• 12.6. Reckitt Benckiser
• 12.7. Pfizer
• 12.8. Vita Life Sciences Ltd
• 12.9. Arazo Nutrition
• 12.10. Nature's Sunshine Products, Inc
• 12.11. Glanbia Plc
• 12.12. Vitawin
• 12.13. Nutramax Laboratories Consumer Care, Inc
• 12.14. Simply Supplements
• 12.15. Love Life Supplements
• 12.16. Now Foods
• 12.17. Bellavita Healthcare Pvt Ltd
• 12.18. Vitaco
• 12.19. Nutravita
• 12.20. Life Extension
• 12.21. Pure Encapsulations, LLC
• 12.22. Herbs Nutriproducts Pvt. Ltd.
• 12.23. Millennium Herbal Care
• 12.24. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations